67% of U.S. SynCardia Certified Centers Make Becker’s 100 Great American Hospitals List
Becker’s Hospital Review Focuses on Cutting-Edge Healthcare Information for Hospital and Healthcare Leaders.
“100 Great Hospitals in America” list published by Becker’s Hospital Review.TUCSON, Ariz. – April 8, 2014 – More than two-thirds, 35, of SynCardia’s 52 Certified Centers in the United States are on the
“When more than a third of America’s top 100 hospitals have the SynCardia temporary Total Artificial Heart it clearly demonstrates that our device is rapidly becoming the standard of care for end-stage biventricular heart failure,” says Michael P. Garippa, SynCardia Systems, Inc. CEO and President.
SynCardia Certified Centers use the SynCardia Total Artificial Heart to save patients dying from end-stage biventricular (both sides) heart failure and bridge them to a donor heart transplant. It is the world's first and only FDA, Health Canada and CE approved Total Artificial Heart.
Like a heart transplant, the SynCardia Total Artificial Heart replaces the two failing heart ventricles and four valves. It is the only approved device in the world that eliminates the source and symptoms of end-stage biventricular heart failure.
Becker’s Hospital Review cited the cardiology and cardiac surgery services at many of these SynCardia hospitals as reasons they were included in the list. The editorial staff of the publication for high-level hospital leaders compiled the list from research efforts, nominations and evaluations of hospital ranking sources such as U.S. News & World Report, Truven Health Analytics and Healthgrades.
There are 97 SynCardia Certified Centers worldwide with an additional 39 hospitals in the process of completing the four-phase certification program. Nearly 1,300 SynCardia Heart implants have been performed worldwide, including 400 since 2011.
›› Read what Becker’s Hospital Review says about its “100 Great Hospitals in America.”
CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463